Buy Delcath Systems Stock | DCTH Stock Price & Latest News | Public.com
DCTH

Delcath Systems

$0.00 (0.00%)Today
    Small Market Cap
    View Delcath Systems (DCTH) stock trends here

    About DCTH

    Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes CHEMOSAT and Melphalan Hydrochloride for Injection, which is a proprietary product used with the Delcath Hepatic Delivery...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.64
    -1.27
    -1.91
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.83

    Actual EPS
    Q1 2021

    Stats

    Market Cap$116M
    Volume92,57k
    Price-to-Earnings Ratio0.26
    Dividend Rate
    Dividend Yield
    1 Year High$25.18
    1 Year Low$6.06
    Open$19.74
    High$19.75
    Low$17.27

    Buy any stock with any amount of money.

    Download the App
    Download the app